Katherine T Lofgren

11.6k total citations · 2 hit papers
19 papers, 1.6k citations indexed

About

Katherine T Lofgren is a scholar working on Cancer Research, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Katherine T Lofgren has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Katherine T Lofgren's work include Cancer Genomics and Diagnostics (8 papers), Lung Cancer Treatments and Mutations (5 papers) and Global Maternal and Child Health (4 papers). Katherine T Lofgren is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Lung Cancer Treatments and Mutations (5 papers) and Global Maternal and Child Health (4 papers). Katherine T Lofgren collaborates with scholars based in United States, Australia and Norway. Katherine T Lofgren's co-authors include Julie Knoll Rajaratnam, Laura Dwyer‐Lindgren, Christopher J L Murray, Alan D López, Mohsen Naghavi, Rafael Lozano, Kyle J Foreman, David Phillips, Charles Atkinson and Haidong Wang and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and American Economic Review.

In The Last Decade

Katherine T Lofgren

17 papers receiving 1.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis

2011 670 citations Rafael Lozano, Haidong Wang et al. The Lancet profile →
Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010

2012 591 citations Haidong Wang, Laura Dwyer‐Lindgren et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katherine T Lofgren United States	9	852	496	349	241	190	19	1.6k
Xing Lin Feng China	20	560 0.7×	419 0.8×	149 0.4×	275 1.1×	205 1.1×	80	1.8k
Louise T. Day United Kingdom	16	1.1k 1.3×	390 0.8×	348 1.0×	106 0.4×	157 0.8×	48	1.5k
Julie Knoll Rajaratnam United States	14	1.6k 1.8×	1.0k 2.1×	716 2.1×	403 1.7×	312 1.6×	18	2.9k
Marianne Vidler Canada	24	1.1k 1.3×	322 0.6×	240 0.7×	111 0.5×	194 1.0×	108	1.6k
Ashish KC Sweden	28	1.6k 1.9×	466 0.9×	468 1.3×	136 0.6×	233 1.2×	124	2.3k
Andrea B Feigl United States	15	325 0.4×	336 0.7×	92 0.3×	155 0.6×	221 1.2×	23	1.3k
Francis Notzon United States	14	711 0.8×	473 1.0×	113 0.3×	104 0.4×	200 1.1×	26	1.6k
Catherine Chojenta Australia	32	1.7k 2.0×	843 1.7×	574 1.6×	324 1.3×	610 3.2×	133	2.9k
Syed Emdadul Haque Bangladesh	16	336 0.4×	278 0.6×	203 0.6×	70 0.3×	224 1.2×	43	1.1k
Supon Limwattananon Thailand	23	633 0.7×	639 1.3×	104 0.3×	662 2.7×	92 0.5×	58	1.4k

Countries citing papers authored by Katherine T Lofgren

Since Specialization

Citations

This map shows the geographic impact of Katherine T Lofgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine T Lofgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine T Lofgren more than expected).

Fields of papers citing papers by Katherine T Lofgren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine T Lofgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine T Lofgren. The network helps show where Katherine T Lofgren may publish in the future.

Co-authorship network of co-authors of Katherine T Lofgren

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine T Lofgren. A scholar is included among the top collaborators of Katherine T Lofgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine T Lofgren. Katherine T Lofgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Sethunath, Vidyalakshmi, Amaya Gascó, Jeffrey S. Ross, et al.. (2025). Coverage of actionable alterations in non-small cell lung cancer by hybrid capture-based FoundationOne®CDx compared with amplicon-based OncomineDX. The Oncologist. 30(12).

Vidal, Gregory A., Neha Jain, Aaron Fisher, et al.. (2024). Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer Treated in the US Community Setting. JCO Oncology Practice. 20(3). 370–377. 3 indexed citations

Lofgren, Katherine T, Jessica Lee, Khaled Tolba, et al.. (2024). Association of Timely Comprehensive Genomic Profiling With Precision Oncology Treatment Use and Patient Outcomes in Advanced Non–Small-Cell Lung Cancer. JCO Precision Oncology. 8(8). e2300292–e2300292. 3 indexed citations

Huang, Richard S.P., Jessica Lee, & Katherine T Lofgren. (2024). Clinical value of comprehensive genomic profiling on clinical trial enrollment for patients with advanced solid tumors. The Oncologist. 30(7).

Mack, Philip C., Gerald Li, Katherine T Lofgren, et al.. (2024). Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC. The Oncologist. 29(8). e984–e996. 5 indexed citations

Vidal, Gregory A., Neha Jain, Aaron J. Fisher, et al.. (2023). Practice- and provider-level inequities in next-generation sequencing (NGS) testing by race/ethnicity for patients (pts) with advanced non-small cell lung cancer (aNSCLC) treated in the community setting.. Journal of Clinical Oncology. 41(16_suppl). 6508–6508. 1 indexed citations

Madison, Russell W., Jay A. Moore, Dexter X. Jin, et al.. (2023). A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic Cancer. The Oncologist. 28(8). 691–698. 11 indexed citations

Schwartzberg, Lee S., Gerald Li, Khaled Tolba, et al.. (2022). Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC. JTO Clinical and Research Reports. 3(9). 100386–100386. 18 indexed citations

Stern, Ariel Dora, Jörg F. Debatin, Julia Hagen, et al.. (2022). Advancing digital health applications: priorities for innovation in real-world evidence generation. The Lancet Digital Health. 4(3). e200–e206. 83 indexed citations

10.

Lofgren, Katherine T, Gerald Li, Khaled Tolba, et al.. (2022). Quantifying the Value of Multigene Testing in Resected Early Stage Lung Adenocarcinoma. Journal of Thoracic Oncology. 18(4). 476–486. 15 indexed citations

11.

Lofgren, Katherine T, Ann Thomas, Andrea Lanes, et al.. (2021). The cost-effectiveness of preimplantation genetic testing for aneuploidy in the United States: an analysis of cost and birth outcomes from 158,665 in vitro fertilization cycles. American Journal of Obstetrics and Gynecology. 225(1). 55.e1–55.e17. 24 indexed citations

12.

Sheinson, Daniel, William B. Wong, Craig S. Meyer, et al.. (2021). Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination. JAMA Network Open. 4(12). e2138219–e2138219. 31 indexed citations

13.

Lofgren, Katherine T, David Watkins, Solomon Tessema Memirie, Joshua A. Salomon, & Stéphane Verguet. (2021). Balancing health and financial protection in health benefit package design. Health Economics. 30(12). 3236–3247. 3 indexed citations

14.

Lofgren, Katherine T, Ann Thomas, Andrea Lanes, et al.. (2019). The cost-effectiveness of preimplantation genetic testing for aneuploidy (PGT-A): an analysis of 153,865 SART cycles. Fertility and Sterility. 112(3). e234–e234. 1 indexed citations

15.

Cohen, Jessica, Katherine T Lofgren, & Margaret McConnell. (2017). Precommitment, Cash Transfers, and Timely Arrival for Birth: Evidence from a Randomized Controlled Trial in Nairobi Kenya. American Economic Review. 107(5). 501–505. 5 indexed citations

16.

Alvarado, Miriam & Katherine T Lofgren. (2013). How can city planners improve health and reduce mortality in Alameda County, California? A cross-sectional analysis. The Lancet. 381. S7–S7. 1 indexed citations

17.

Lozano, Rafael, Kyle J Foreman, Julie Knoll Rajaratnam, et al.. (2012). Progress Toward Millennium Development Goals 4 and 5 on Maternal and Child Mortality. Obstetric Anesthesia Digest. 32(3). 164–165. 158 indexed citations

18.

Wang, Haidong, Laura Dwyer‐Lindgren, Katherine T Lofgren, et al.. (2012). Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 380(9859). 2071–2094. 591 indexed citations breakdown →

19.

Lozano, Rafael, Haidong Wang, Kyle J Foreman, et al.. (2011). Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. The Lancet. 378(9797). 1139–1165. 670 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact